Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
| CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | miRNA | cotransfection (plasmid/miRNA) | K2 Transfection System | publication | Z. Cai et al., Exp. & Mol. Med., 2018, 50:45, DOI 10.1038/s12276-018-0068-3 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | G. Granja-Galeano et al., Biochemical Pharmacology, 2017, 146: 117-126 | |||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | C. I. McCarthy et al., J. Gen. Physiol., 2020, 152, 5: e201912492, doi.org/10.1085/jgp.201912492 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note |  |
|||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | C. Stegmann et al., J. of Virology, 2019, 93: 11, e00138-19, doi.org/10.1128/JVI.00138-19 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | |
|||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/miRNA) | K2 Transfection System | publication | Z. Cai et al., Exp. & Mol. Med., 2018, 50:45, DOI 10.1038/s12276-018-0068-3 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | C. D. Zappia et al., Cells, 2021, 10, 3026, doi.org/10.3390/cells10113026 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | E. Echeverría et al., Front. Pharmacol., 2020, 11: 113, doi: 10.3389/fphar.2020.00113 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | C. Zappia et al., Pharmacol. Res. Perspect, 2019, e00531, DOI: 10.1002/prp2.531 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | V. Burghi et al., Front. Pharmacol., 2019, 10: 146, doi: 10.3389/fphar.2019.00146 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | B. Giotti et al., J. Mol. Cell Biol., 2019, 11(8): 703–718, doi:10.1093/jmcb/mjy063 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | CRISPR | K2 Transfection System | publication | D. Marks et al., bioRxiv preprint, 2021, doi.org/10.1101/2021.09.15.460502 | Link | |
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | |
|||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | A. Rodrıguez Gonzalez et al., The FEBS J., 2020, 288:229–243, doi:10.1111/febs.15344 | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | L. Iarriccio et al., PLOS ONE, 2015, DOI:10.1371/journal.pone.0142980 | Link | |
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | plasmid | K2 Transfection System | application note | |
|||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Kullmann, 2016, Rheinische Friedrich-Wilhelms-Universität Bonn | Link | ||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | |
|||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | |
|||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | |
|||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Kullmann, 2016, Rheinische Friedrich-Wilhelms-Universität Bonn | Link | ||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | |
|||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link | ||
A375 |
Human skin malignant melanoma cell line | ATCC CRL-1619 | Human | skin | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Front. Cell Dev. Biol., 2021, 9: 718947, doi: 10.3389/fcell.2021.718947 | Link |
 |
Fax-Bestellung |
Geben Sie Ihre Bestellung einfach und bequem per Fax auf unter folgender Nummer:
0049 89 32479952
Europa
0049 89 32479952
USA/Kanada
01149 89 32479952
Australien
001149 89 32479952
 |
Email-Bestellung |
Geben Sie Ihre Bestellung einfach und bequem per Email auf unter folgender Adresse: order@biontex.com
 |
Online-Bestellung |
Für die korrekte Darstellung der Preise und Versandkosten ist die Wahl Ihrer Region nötig.